Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Snapshot

Acute on chronic liver failure in cirrhosis

Marta Tonon, Salvatore Piano

Clin Mol Hepatol. 2022;28(2):273-275. Published online February 14, 2022

DOI: https://doi.org/10.3350/cmh.2022.0036

View: 6982 Download: 242 Web of Science: 3 Crossref: 3

Letter to the Editor

Reply: Letter: cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis

Jihyun An, Ju Hyun Shim

Clin Mol Hepatol. 2022;28(2):267-268. Published online January 18, 2022

DOI: https://doi.org/10.3350/cmh.2022.0013

View: 3471 Download: 61

Letter: cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis

Yi-Chun Huang, Chih-Wei Chen, James Chun-Chung Wei

Clin Mol Hepatol. 2022;28(2):265-266. Published online January 4, 2022

DOI: https://doi.org/10.3350/cmh.2021.0412

View: 7215 Download: 44 Web of Science: 1 Crossref: 1

Original Article

Galectin-3 inhibits cardiac contractility via a tumor necrosis factor alpha-dependent mechanism in cirrhotic rats

Ki Tae Yoon, Hongqun Liu, Jing Zhang, Sojung Han, Samuel S. Lee

Clin Mol Hepatol. 2022;28(2):232-241. Published online January 5, 2022

DOI: https://doi.org/10.3350/cmh.2021.0141

View: 6314 Download: 128 Web of Science: 7 Crossref: 9

Association between serum tumor necrosis factor-α and sarcopenia in liver cirrhosis

Ji Won Han, Da In Kim, Hee Chul Nam, U Im Chang, Jin Mo Yang, Do Seon Song

Clin Mol Hepatol. 2022;28(2):219-231. Published online July 20, 2021

DOI: https://doi.org/10.3350/cmh.2021.0082

View: 20035 Download: 343 Web of Science: 20 Crossref: 19

Editorial

Leaky gut-derived tumor necrosis factor-α causes sarcopenia in patients with liver cirrhosis

Takumi Kawaguchi, Takuji Torimura

Clin Mol Hepatol. 2022;28(2):177-180. Published online August 26, 2021

DOI: https://doi.org/10.3350/cmh.2021.0246

View: 5655 Download: 185 Web of Science: 4 Crossref: 4

Review

The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: Advantages and pitfalls

Hae Lim Lee, Sung Won Lee

Clin Mol Hepatol. 2022;28(2):121-134. Published online September 27, 2021

DOI: https://doi.org/10.3350/cmh.2021.0239

View: 7786 Download: 407 Web of Science: 21 Crossref: 21

Original Article

U-shaped relationship between urea level and hepatic decompensation in chronic liver diseases

Huapeng Lin, Grace Lai-Hung Wong, Xinrong Zhang, Terry Cheuk-Fung Yip, Ken Liu, Yee Kit Tse, Vicki Wing-Ki Hui, Jimmy Che-To Lai, Henry Lik-Yuen Chan, Vincent Wai-Sun Wong

Clin Mol Hepatol. 2022;28(1):77-90. Published online November 5, 2021

DOI: https://doi.org/10.3350/cmh.2021.0188

View: 6901 Download: 157 Web of Science: 18 Crossref: 17

Cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis

Jihyun An, Hyung-Don Kim, Seon-Ok Kim, Ha Il Kim, Gi-Won Song, Han Chu Lee, Ju Hyun Shim

Clin Mol Hepatol. 2022;28(1):67-76. Published online October 12, 2021

DOI: https://doi.org/10.3350/cmh.2021.0202

View: 5635 Download: 183 Web of Science: 2 Crossref: 2

Review

Current knowledge about biomarkers of acute kidney injury in liver cirrhosis

Han Ah Lee, Yeon Seok Seo

Clin Mol Hepatol. 2022;28(1):31-46. Published online August 2, 2021

DOI: https://doi.org/10.3350/cmh.2021.0148

View: 7683 Download: 332 Web of Science: 14 Crossref: 16

Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis

Ho Soo Chun, A Reum Choe, Minjong Lee, Yuri Cho, Hwi Young Kim, Kwon Yoo, Tae Hun Kim

Clin Mol Hepatol. 2021;27(4):535-552. Published online June 16, 2021

DOI: https://doi.org/10.3350/cmh.2021.0109

View: 12207 Download: 645 Web of Science: 9 Crossref: 9

Changes in the epidemiology and management of bacterial infections in cirrhosis

Salvatore Piano, Marta Tonon, Paolo Angeli

Clin Mol Hepatol. 2021;27(3):437-445. Published online January 28, 2021

DOI: https://doi.org/10.3350/cmh.2020.0329

View: 8858 Download: 432 Web of Science: 36 Crossref: 41

β-blockers in advanced cirrhosis: More friend than enemy

Ki Tae Yoon, Hongqun Liu, Samuel S. Lee

Clin Mol Hepatol. 2021;27(3):425-436. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0234

View: 7907 Download: 290 Web of Science: 30 Crossref: 29

Anti-fibrotic treatments for chronic liver diseases: The present and the future

Naoshi Odagiri, Tsutomu Matsubara, Misako Sato-Matsubara, Hideki Fujii, Masaru Enomoto, Norifumi Kawada

Clin Mol Hepatol. 2021;27(3):413-424. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0187

View: 15385 Download: 499 Web of Science: 29 Crossref: 31

Original Article

Association between new-onset liver cirrhosis and suicide risk in South Korea: A nationwide cohort study

Suk-Yong Jang, Woo Sun Rou, Seok Hyun Kim, Byung Seok Lee, Hyuk Soo Eun

Clin Mol Hepatol. 2021;27(2):283-294. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0227

View: 6886 Download: 202 Web of Science: 10 Crossref: 11

Editorial

A need for patient-centered care in managing patients with liver cirrhosis

Eileen L. Yoon

Clin Mol Hepatol. 2021;27(2):270-272. Published online January 27, 2021

DOI: https://doi.org/10.3350/cmh.2021.0001

View: 4156 Download: 121 Web of Science: 2 Crossref: 2

Original Article

The cut-off value of transient elastography to the value of hepatic venous pressure gradient in alcoholic cirrhosis

Se Ri Ryu, Jeong-Ju Yoo, Seong Hee Kang, Soung Won Jeong, Moon Young Kim, Young Kyu Cho, Young Chang, Sang Gyune Kim, Jae Young Jang, Young Seok Kim, Soon Koo Baik, Yong Jae Kim, Su Yeon Park, Baigal Baymbajav

Clin Mol Hepatol. 2021;27(1):197-206. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0171

View: 7962 Download: 189 Web of Science: 11 Crossref: 11

Alcohol associated liver cirrhotics have higher mortality after index hospitalization: Long-term data of 5,138 patients

Priyanka Jain, Saggere Muralikrishna Shasthry, Ashok Kumar Choudhury, Rakhi Maiwall, Guresh Kumar, Ankit Bharadwaj, Vinod Arora, Rajan Vijayaraghavan, Ankur Jindal, Manoj Kumar Sharma, Vikram Bhatia, Shiv Kumar Sarin

Clin Mol Hepatol. 2021;27(1):175-185. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0068

View: 6107 Download: 143 Web of Science: 14 Crossref: 14

Editorial

Marta Tonon, Salvatore Piano

Clin Mol Hepatol. 2021;27(1):94-96. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0305

View: 5160 Download: 147 Web of Science: 7 Crossref: 7

The cutoff of transient elastography for the evaluation of portal hypertension should be different according to the etiology?

Beom Kyung Kim

Clin Mol Hepatol. 2021;27(1):91-93. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0311

View: 4328 Download: 92 Web of Science: 5 Crossref: 6

Review

The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future

Yusuke Watanabe, Atsunori Tsuchiya, Shuji Terai

Clin Mol Hepatol. 2021;27(1):70-80. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0194

View: 13449 Download: 417 Web of Science: 91 Crossref: 91

Managing liver cirrhotic complications: Overview of esophageal and gastric varices

Cosmas Rinaldi Adithya Lesmana, Monica Raharjo, Rino A. Gani

Clin Mol Hepatol. 2020;26(4):444-460. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0022

View: 14531 Download: 719 Web of Science: 62 Crossref: 66

Role of cytoglobin, a novel radical scavenger, in stellate cell activation and hepatic fibrosis

Le Thi Thanh Thuy, Hoang Hai, Norifumi Kawada

Clin Mol Hepatol. 2020;26(3):280-293. Published online June 4, 2020

DOI: https://doi.org/10.3350/cmh.2020.0037

View: 8771 Download: 241 Web of Science: 14 Crossref: 15

Letter to the Editor

Multimodal sequential treatment for occluded TIPS: Case report and review of literature

Nicoletta De Matthaeis, Carmine Di Stasi, Fabrizio Pizzolante, Riccardo Manfredi, Gian Ludovico Rapaccini, Luca Miele

Clin Mol Hepatol. 2020;26(2):227-230. Published online November 18, 2019

DOI: https://doi.org/10.3350/cmh.2019.0056

View: 6650 Download: 164

Guideline

KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications

The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol. 2020;26(2):83-127. Published online January 10, 2020

DOI: https://doi.org/10.3350/cmh.2019.0010n

View: 23300 Download: 1,381 Web of Science: 82 Crossref: 79

Letter to the Editor

Clinical characteristics of portal hypertension complicated by gastroesophageal varices in patients with myeloproliferative neoplasms

Jaejun Lee, Pil Soo Sung, Ki-Seong Eom, Hyun Yang, Soon Kyu Lee, Aung Hlaing Bwa, Angelo Lozada, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon

Clin Mol Hepatol. 2020;26(1):78-82. Published online November 26, 2019

DOI: https://doi.org/10.3350/cmh.2019.0078

View: 6918 Download: 181 Web of Science: 6 Crossref: 5

Transjugular intrahepatic portosystemic shunt assisted with trans-splenic access

Zhang Cheng, Feng Wang, Jianfei Liu

Clin Mol Hepatol. 2019;25(4):417-419. Published online June 19, 2019

DOI: https://doi.org/10.3350/cmh.2019.0030

View: 5224 Download: 123

Original Article

Incidence and risk factors of dysphagia after variceal band ligation

Saraswathi Arasu, Hammad Liaquat, Jaspreet Suri, Adam C. Ehrlich, Frank K. Friedenberg

Clin Mol Hepatol. 2019;25(4):374-380. Published online July 18, 2019

DOI: https://doi.org/10.3350/cmh.2019.0019

View: 6860 Download: 189 Web of Science: 2 Crossref: 2

Review

Sarcopenia: Ammonia metabolism and hepatic encephalopathy

Ankur Jindal, Rakesh Kumar Jagdish

Clin Mol Hepatol. 2019;25(3):270-279. Published online April 22, 2019

DOI: https://doi.org/10.3350/cmh.2019.0015

View: 17972 Download: 952 Web of Science: 71 Crossref: 76

Original Article

Portal pressure gradient and serum albumin: A simple combined parameter associated with the appearance of ascites in decompensated cirrhosis treated with transjugular intrahepatic portosystemic shunt

Dongmei Zhao, Guobing Zhang, Mingquan Wang, Chaoxue Zhang, Jiabin Li

Clin Mol Hepatol. 2019;25(2):210-217. Published online March 22, 2019

DOI: https://doi.org/10.3350/cmh.2018.0083

View: 6675 Download: 127 Web of Science: 7 Crossref: 7

Viewed By 6392	MAFLD: How is it different from NAFLD?
Viewed By 5478	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 5154	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4228	Examining the therapeutic landscape of beta-blockers in portal hypertension
Viewed By 4013	Gut microbiome and metabolome signatures in liver cirrhosis-related complications

Cited By 272	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 230	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 156	MAFLD: How is it different from NAFLD?
Cited By 79	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 76	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Cirrhosis and portal hypertension